Corning acquires Mediatech

NewsGuard 100/100 Score

Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.

Mediatech develops, manufactures and sells a broad range of high quality cell culture media and molecular biology reagents related to tissue and cell culture applications, including culture media, basal salt solutions, antibiotics, sera, specialty media and flexible packaging systems, under the cellgro® brand.

David Kroin, Managing Director of Great Point Partners, said, "From our original thematic review of the biologics manufacturing supply chain, we identified cell culture media as an attractive sector for investment and sought out Mediatech as a leading player in this segment. Corning's acquisition of Mediatech has confirmed the validity of our thesis and we are thrilled with the combination. Mediatech's loyal customer base, and the strength of the cellgro® brand name in the U.S., underpin its strategic value."

"By providing customers worldwide with greater access to Mediatech's cellgro® product portfolio, this acquisition supports Corning's ongoing commitment to supply its customers with a comprehensive line of laboratory research tools," said Richard Eglen, General Manager Corning Life Sciences.

Mediatech's wide array of culture media and molecular biology reagents are complementary to the general labware, cell culture, lab equipment, and HTS/Assay products offered today by Corning. In addition, the acquisition enables Corning to continue to improve its strategic balance by strengthening its Life Sciences segment.

James DeOlden, co-founder of Mediatech, will serve in an advisory capacity during the leadership transition. Regarding this transaction, DeOlden said, "I am very happy to be working with the Corning organization to expand the market access for Mediatech's high quality products and solutions."

SOURCE Great Point Partners

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map all yeast proteins across cell cycle for the first time